Key result
Atrial fibrillation linked to ~42% higher all-cause mortality in patients with inflammatory bowel disease.
Why the study?
Given increasing evidence linking systemic inflammation to atrial fibrillation development, the authors evaluated the impact of atrial fibrillation on inpatient outcomes, resource utilization, and length of hospital stay in IBD patients.
Does comorbid atrial fibrillation increase the risk of all-cause mortality and other adverse outcomes in patients with inflammatory bowel disease?
Meta-Analysis (n=842,149)
Does comorbid atrial fibrillation increase the risk of all-cause mortality and other adverse outcomes in patients with inflammatory bowel disease?
In patients with inflammatory bowel disease, comorbid atrial fibrillation is associated with a 42% increased risk of all-cause mortality, highlighting the need for early identification and integrated management.
Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract, often leading to symptoms like abdominal pain and diarrhea. Given the increasing evidence linking systemic inflammation to atrial fibrillation development, investigating IBD as a potential risk factor for atrial fibrillation becomes imperative. This meta-analysis aims to evaluate the impact of atrial fibrillation on inpatient outcomes, resource utilization, and length of hospital stays among IBD patients. Following the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020 guidelines, a systematic literature search was conducted across multiple databases, including Embase, PubMed, Scopus, and Web of Science, from the inception of databases to June 5, 2024. Eligible studies included prospective or retrospective studies with definitive diagnoses of ulcerative colitis, Crohn's disease, or IBD, demonstrating the influence of atrial fibrillation. Data were extracted, and quality assessment was performed using the Newcastle-Ottawa Scale. The meta-analysis comprised 842,149 IBD patients, with 71,221 having atrial fibrillation. Pooled analysis revealed a significant association between atrial fibrillation and heightened all-cause mortality risk (risk ratio (RR): 1.42, 95% confidence interval (CI): 1.16 to 1.74, p<0.01). However, no significant differences were observed in the incidence of acute myocardial infarction, acute kidney injury, or acute respiratory failure between patients with and without atrial fibrillation. IBD patients with comorbid atrial fibrillation face higher mortality rates, potentially due to systemic inflammation, thromboembolism risks, polypharmacy, and the complexities of managing both conditions concurrently. Early identification and integrated management of atrial fibrillation in IBD patients are crucial to improving outcomes. Larger, multi-center studies are needed to explore the underlying mechanisms and develop tailored treatment strategies.
No takes yet. Share an insight, caveat, or question.
Suhagiya et al. (2024) conducted a meta-analysis in Inflammatory Bowel Disease (n=842,149). Atrial Fibrillation vs. No Atrial Fibrillation was evaluated on All-cause mortality (RR 1.42, 95% CI 1.16 to 1.74, p=<0.01). Atrial fibrillation significantly increased the risk of all-cause mortality (RR 1.42) in patients with inflammatory bowel disease compared to those without atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: